|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.55 CNY | -0.41% |
|
+2.62% | +10.95% |
Chart calendar DaShenLin Pharmaceutical Group Co., Ltd.
Upcoming events on DaShenLin Pharmaceutical Group Co., Ltd.
| 22/04/2026 | Q1 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 23/04/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format |
| 01/09/2026 | Q2 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 28/10/2026 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 28/04/2027 | Q1 2027 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past events on DaShenLin Pharmaceutical Group Co., Ltd.
| 29/10/2025 | Q3 2025 Earnings Release |
| 28/08/2025 | Q2 2025 Earnings Release |
| 28/04/2025 | Q4 2024 Earnings Release |
| 25/04/2025 | Q1 2025 Earnings Release |
| 30/10/2024 | Q3 2024 Earnings Release |
| 18/07/2024 | Extraordinary Shareholders Meeting |
| 20/05/2024 | Annual General Meeting |
| 28/04/2024 | Q4 2023 Earnings Release |
| 27/04/2024 | Q1 2024 Earnings Release |
| 01/04/2024 | Extraordinary Shareholders Meeting |
| 08/02/2024 | Extraordinary Shareholders Meeting |
| 29/12/2023 | Extraordinary Shareholders Meeting |
| 30/10/2023 | Q3 2023 Earnings Release |
| 29/08/2023 | Q2 2023 Earnings Release |
| 19/05/2023 | Annual General Meeting |
| 27/04/2023 | Q4 2022 Earnings Release |
| 27/04/2023 | Q1 2023 Earnings Release |
| 12/04/2023 | Extraordinary Shareholders Meeting |
| 13/03/2023 | Extraordinary Shareholders Meeting |
| 03/02/2023 | Extraordinary Shareholders Meeting |
Past dividends on DaShenLin Pharmaceutical Group Co., Ltd.
| 05/11/2025 | Interim Payment 0.34 CNY |
| 18/06/2025 | Final Payment 0.31 CNY |
| 22/10/2024 | Interim Payment 0.31 CNY |
| 20/06/2024 | Annual 0.31 CNY |
| 08/06/2023 | Annual 0.6 CNY |
| 12/06/2022 | Annual 0.5 CNY |
| 09/06/2021 | Annual 0.8 CNY |
| 16/06/2020 | Annual 0.6 CNY |
| 29/05/2019 | Annual 0.6 CNY |
| 18/06/2018 | Annual 0.6 CNY |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 21 248 20 468 3.81% | 24 531 24 720 -0.76% | 26 497 26 779 -1.05% | 27 582 | 30 825 | 33 849 |
|
EBITDA Million CNY | Released Forecast Spread | 1 883 2 263 -16.81% | 2 119 2 532 -16.31% | 3 395 3 349 1.4% | 3 272 | 3 732 | 4 333 |
|
EBIT Million CNY | Released Forecast Spread | 1 421 1 493 -4.85% | 1 632 1 868 -12.66% | 1 501 1 673 -10.32% | 1 872 | 2 195 | 2 602 |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 1 415 1 477 -4.18% | 1 628 1 807 -9.91% | 1 340 1 496 -10.42% | 1 693 | 2 060 | 2 437 |
|
Net income Million CNY | Released Forecast Spread | 1 036 1 098 -5.65% | 1 166 1 303 -10.51% | 915 1 152 -20.57% | 1 180 | 1 435 | 1 695 |
|
EPS CNY | Released Forecast Spread | 0,91 0,98 -7.38% | 1,03 1,15 -10.59% | 0,81 1,05 -23.07% | 1,03 | 1,26 | 1,49 |
| Announcement Date | 27/04/23 | 28/04/24 | 25/04/25 | - |
Quarterly results
| Fiscal Period | September | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 6 752 6 842 -1.32% | 6 593 7 259 -9.17% | 6 386 6 364 0.34% | 6 766 7 282 -7.09% | 6 956 7 159 -2.84% | 6 567 7 200 -8.79% | 6 546 6 554 -0.12% | 7 280 | 7 227 | 7 270 | 7 445 | 7 702 | 7 746 | 8 419 | 8 419 |
|
EBITDA Million CNY | Released Forecast Spread | 571 930 -38.59% | 953 | 851 | 613 | 827 | 882 | 791 | 621 | 1 057 | 1 008 | 1 113 | 484 | 1 181 | 1 132 | 1 253 |
|
EBIT Million CNY | Released Forecast Spread | 571 541 5.61% | 369 618 -40.34% | 295 422 -30.2% | 230 | 650 | 476 403 18% | 410 330 24.26% | 196 | 569 | 535 | 612 | 73,9 | 752 | 702 | 824 |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 572 509 12.27% | 329 498 -33.97% | 278 384 -27.52% | 160 146 10% | 649 362 79.29% | 474 404 17.44% | 398 314 26.73% | 153 | 641 | 592 | 697 | 67,4 | 740 | 689 | 811 |
|
Net income Million CNY | Released Forecast Spread | 398 470 -15.22% | 259 357 -27.39% | 201 275 -27.16% | 56,6 75,8 -25.28% | 460 255 80.19% | 338 276 22.59% | 283 192 47% | 91,6 | 503 | 442 | 547 | -94,2 | 578 | 514 | 635 |
|
EPS CNY | Released Forecast Spread | 0,35 0,32 10.79% | 0,23 0,36 -36.31% | 0,18 0,24 -24.13% | 0,06 0,11 -44.88% | 0,40 0,31 29.85% | 0,30 0,24 22.92% | 0,25 0,18 39.3% | 0,07 | 0,38 | 0,31 | 0,34 | 0,11 | 0,51 | 0,45 | 0,56 |
| Announcement Date | 28/04/24 | 30/08/24 | 30/10/24 | 25/04/25 | 25/04/25 | 28/08/25 | 29/10/25 | - | - | - | - | - | - | - | - |
| 12/02/2026 | Q3 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 19/02/2026 | January 2026 Sales and Revenue Release | Add to your calendar Google Apple ICS format | |
| 03/03/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 03/03/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 11/03/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 15/03/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 19/03/2026 | February 2026 Sales and Revenue Release | Add to your calendar Google Apple ICS format | |
| 22/03/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 25/03/2026 | Q2 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 29/03/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past sector events for DaShenLin Pharmaceutical Group Co., Ltd.
| 04/02/2026 | Q4 2025 Earnings Release | |
| 30/01/2026 | Q3 2026 Earnings Release | |
| 26/01/2026 | Q2 2025 Earnings Release | |
| 19/01/2026 | December 2025 Sales and Revenue Release | |
| 13/01/2026 | Q3 2025 Earnings Release (Projected) | |
| 31/12/2025 | Q1 2026 Earnings Release (Projected) | |
| 21/12/2025 | November 2025 Sales and Revenue Release | |
| 29/11/2025 | Q3 2025 Earnings Release | |
| 26/11/2025 | Q2 2026 Earnings Release | |
| 20/11/2025 | October 2025 Sales and Revenue Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 603233 Stock
- Calendar DaShenLin Pharmaceutical Group Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















